Tag Archives: National Institutes of Health

The Hill: Will Support for Biomedical Research Be Dead on Arrival?

ebola

In an op-ed over at The Hill, Dr. Claire Pomeroy, an infectious disease specialist and president of the Albert and Mary Lasker Foundation, discusses an important question: “How is it that the United States, which has historically held the global lead in medical innovation, was caught flat-footed by Ebola?” Dr. Pomeroy points to a lack of federal funding for medical research as one of the primary culprits for our lack of effective Ebola answers, a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Kay Holcomb

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading Biopharma Firms Mobilize to Tackle Tough Diseases – discussed the new Accelerating Medicines Partnership (AMP) program, which is aimed at transforming the current model for developing new treatments by jointly identifying and validating promising biological targets of disease. AMP is a new venture among the NIH, several non-profit organizations and 10 biopharmaceutical companies focused on Alzheimer’s disease; type 2 diabetes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

NIH & NSF SBIR/STTR Programs

InnovationZone_Logo_SBIR Companies_VERT_lockup

Leveraging Small Business to Bring Life-Saving Innovations to the Market. A key part of the National Institutes of Health (NIH) and the National Science Foundation (NSF)’s mission is the translation of basic discoveries into innovative technologies that improve human health, and the NIH and NSF Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs strive to do just that. NIH is the premier biomedical research funding organization in the world, and has a 2014 SBIR/STTR Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

BIO to Labor/HHS: Increase Funding for Critical Public Health Programs

patient

BIO sent a letter to appropriators to encourage support for programs and initiatives that are of great importance to the American public and the advancement of public health, and that will help meet our nation’s unmet medical needs. Specifically, we request the following: National Institutes of Health (NIH): We request that the Committee provide NIH with at least $32 billion. Since the doubling of the NIH funding between 1998 and 2003, funding has failed to Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

Dent

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, co- chair of the Congressional Biomedical Research Caucus, joined BIO’s Fritz Bittenbender to discuss the biotech industry in Pennsylvania as well as recent legislative developments affecting the industry. Dent points to the recent omnibus spending agreement which allowed the Food and Drug Administration (FDA) to access user $85 million in user fees sequestered in 2013. These fees are paid to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,